Contrary to the typical apoptotic size distribution, the work by Mouliere and colleagues [12, 13] described KRAS mutated ctDNA fragments from colorectal cancer patients which were mainly smaller than 145 – 160 bp as compared to circulating DNA from KRAS wild type patients and non-tumoral derived circulating DNA from healthy cells. Here, KRAS is linked to colorectal cancer.